When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
The FDA has granted Fast Track designation to Arvinas' (NASDAQ:ARVN), lead PROTAC protein degrader, ARV-110, for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed after treatment with two or more systemic therapies.
More news on: Arvinas, Inc., Healthcare stocks news,